TABLE 2 Compounds commonly reported in the literature that may induce hemolysis in G6PD deficient individuals (compiled from: Avery, 1980; Koda-Kimble, 1978).

NOTE: Table entries read down.


ANALGESICS/ANTIPYRETICS

MISCELLANEOUS

acetanilid alpha-methyldopa
acetophenetidin (phenacetin) ascorbic acid
amidopyrine (aminopyrine) dimercaprol (BAL)
antipyrine hydralazine
aspirin mestranol
phenacetin methylene blue
probenicid nalidixic acid
pyramidone naphthalene

ANTIMALARIALS

niridazole
chloroquine phenylhydrazine
hydroxychloroquine pyridium
mepacrine (quinacrine) quinine
pamaquine toluidine blue
pentaquine trinitrotoluene
primaquine urate oxidase
quinine vitamin K (water soluble)
quinocide

CYTOTOXIC/ANTIBACTERIAL

CARDIOVASCULAR DRUGS

chloramphenicol
procainamide co-trimoxazole
quinidine furazolidone

SULFONAMIDES/SULFONES

furmethonol
dapsone nalidixic acid
sulfacetamide neoarsphenamine
sulfamethoxypyrimidine nitrofurantoin
sulfanilamide nitrofurazone
sulfapyridine PAS
sulfasalazine para-aminosalicylic acid
sulfisoxazole PLEASE READ DISCLAIMER



CLINICAL ASPECTS | G6PD DEFICIENCY HOMEPAGE | MOLECULAR BIOLOGY